9/9/2017BGI Secures CLIA Certification for Its Lab in Hong Kong

9/9/2017Eli Lilly to Close Its R&D Center in Shanghai

9/9/2017WuXi NextCODE Completes $240 Million Series B Financing

9/7/2017Recent Executive Moves

9/7/2017CAS and Innovent Form Partnership for Development of Cancer Immunology...

9/7/2017Zhejiang Huahai Enters Equity and Licensing Agreements with Korea's Eu...

9/7/2017Palatin Announces Licensing Agreement with Fosun Pharma for Bremelanot...

9/6/2017CFDA Announces New Dossier and Stability Study Requirements for Specia...

9/6/2017Central Government Holds Promotional Conference for Medical Consortium...

9/4/2017Superbug Drug Developer Destiny Ties Up with CMS on Aim Debut

9/4/2017TPG Buys CRO OPC Holding for A Slice of China's Clinical Trial Boom

9/4/2017Review of Chinese Foreign Trade of Western Medicines in H1

9/4/2017Fosun Buys U.S. Rights of Ten Generic Drugs from Sandoz

9/4/2017Speech by CFDA Minister Bi Jingquan at the Inaugurating Conference of ...

9/3/20173SBio Acquires Therapure's Canadian Bio-manufacturing Business

9/1/2017Why China's Traditional Medicine Boom Is Dangerous

8/31/2017Recent Executive Moves

8/31/2017Most Domestically-listed Pharma Companies Showed Net Profit Growth in ...

8/31/2017CFDA Solicits Comments on Rules for Overseas Drug Inspections

8/30/2017MOLOGEN and iPharma Sign Binding Term Sheet for Licensing, Co-developm...

8/30/2017Preparation of the Chinese Pharmacopoeia 2020 Began with CFDA Announci...

8/30/2017China Approves Janssen's BTK Inhibitor IMBRUVICA

8/30/2017Chi-Med Initiates a Phase I Trial of Selective PI3Kδ Inhibitor in Lym...

8/29/2017CFDA Issues Guideline for Chemical Drug Manufacturing Process Changes

8/28/2017Chinese Patients Head to India for Latest Medicines after Domestic Cra...

8/28/2017GNC in Deal with Alipay to Make Purchase Easier for Chinese Customers

8/28/2017CF PharmaTech Raises CNY 440M in Series D Round Led by SDIF Fund

8/28/2017Trump's Secret Weapon Against Unfair Trade Is the FCPA

8/28/2017China Resources Pharma Delivers Solid Interim H1 Results

8/28/2017Shanghai Pharma Reports Healthy Growth in H1 Interim Results

Page:155/334 Total number of articles:10001: [First][<<] [153] [154] [155] [156] [157] [>>] [End]